abstract |
The invention relates to an adenovirus comprising a sequence corresponding to the formula (I) 5'ITR-B1-BA-B2-BX-BB-BY-B3-3'ITR wherein Βγ comprises a transgene cassette containing four transgenes, said genes encoding FAP-BITE, CXLI O, CXL9 and IFN. The invention also relates to a pharmaceutical composition comprising the virus, and the use of the virus or formulation as a treatment. |